Chemotherapy Options beyond the First Line in HER-Negative Metastatic Breast Cancer

por Lorusso, Vito, Latorre, Agnese, Giotta, Francesco
Publicado en J Oncol (2020)

Management of Chemotherapy-Induced Nausea and Vomiting (CINV): A Short Review on the Role of Netupitant-Palonosetron (NEPA)

por Lorusso, Vito, Russo, Anna, Giotta, Francesco, Codega, Paolo
Publicado en Core Evid (2020)

Independent Negative Prognostic Role of TCF1 Expression within the Wnt/β-Catenin Signaling Pathway in Primary Breast Cancer Patients

por Saponaro, Concetta, Scarpi, Emanuela, Zito, Francesco Alfredo, Giotta, Francesco, Silvestris, Nicola, Mangia, Anita
Publicado en Cancers (Basel) (2019)

FISH testing of HER2 immunohistochemistry 1+ invasive breast cancer with unfavorable characteristics

por Petroni, Stella, Caldarola, Lucia, Scamarcio, Rachele, Giotta, Francesco, Latorre, Agnese, Mangia, Anita, Simone, Giovanni
Publicado en Oncol Lett (2016)

NHERF1 together with PARP1 and BRCA1 expression as a new potential biomarker to stratify breast cancer patients

por Mangia, Anita, Scarpi, Emanuela, Partipilo, Giulia, Schirosi, Laura, Opinto, Giuseppina, Giotta, Francesco, Simone, Giovanni
Publicado en Oncotarget (2017)

Tumor Infiltrating Lymphocytes and NHERF1 Impact on Prognosis of Breast Cancer Patients

por Schirosi, Laura, Saponaro, Concetta, Giotta, Francesco, Popescu, Ondina, Pastena, Maria Irene, Scarpi, Emanuela, Mangia, Anita
Publicado en Transl Oncol (2019)

The effects of fluorouracil, epirubicin, and cyclophosphamide (FEC60) on the intestinal barrier function and gut peptides in breast cancer patients: an observational study

por Russo, Francesco, Linsalata, Michele, Clemente, Caterina, D’Attoma, Benedetta, Orlando, Antonella, Campanella, Giovanna, Giotta, Francesco, Riezzo, Giuseppe
Publicado 2013

Complete response in a patient with liver metastases from breast cancer employing hepatic arterial infusion 5-fluorouracil based chemotherapy plus systemic nab-paclitaxel

por Ranieri, Girolamo, Marech, Ilaria, Porcelli, Mariangela, Giotta, Francesco, Palmiotti, Gennaro, Laricchia, Giuseppe, Fazio, Vito, Gadaleta, Cosmo Damiano
Publicado en Oncotarget (2017)

Should Tumor Infiltrating Lymphocytes, Androgen Receptor, and FOXA1 Expression Predict the Clinical Outcome in Triple Negative Breast Cancer Patients?

por Mangia, Anita, Saponaro, Concetta, Vagheggini, Alessandro, Opinto, Giuseppina, Centonze, Matteo, Vicenti, Chiara, Popescu, Ondina, Pastena, Maria, Giotta, Francesco, Silvestris, Nicola
Publicado en Cancers (Basel) (2019)

NHERF1 and tumor microenvironment: a new scene in invasive breast carcinoma

por Saponaro, Concetta, Vagheggini, Alessandro, Scarpi, Emanuela, Centonze, Matteo, Catacchio, Ivana, Popescu, Ondina, Pastena, Maria Irene, Giotta, Francesco, Silvestris, Nicola, Mangia, Anita
Publicado en J Exp Clin Cancer Res (2018)

Administration of Angiotensin-Converting Enzyme Inhibitors and β-Blockers During Adjuvant Trastuzumab Chemotherapy for Nonmetastatic Breast Cancer: Marker of Risk or Cardioprotecti...

por Oliva, Stefano, Cioffi, Giovanni, Frattini, Silvia, Simoncini, Edda Lucia, Faggiano, Pompilio, Boccardi, Lidia, Pulignano, Giovanni, Fioretti, Agnese Maria, Giotta, Francesco, Lestuzzi, Chiara, Maurea, Nicola, Sabatini, Silvia, Tarantini, Luigi
Publicado 2012

A multicenter prospective phase II randomized trial of epirubicin/vinorelbine versus pegylated liposomal doxorubicin/vinorelbine as first-line treatment in advanced breast cancer....

por Vici, Patrizia, Colucci, Giuseppe, Giotta, Francesco, Sergi, Domenico, Filippelli, Gianfranco, Perri, Pasquale, Botti, Claudio, Vizza, Enrico, Carpino, Armando, Pizzuti, Laura, Latorre, Agnese, Giannarelli, Diana, Lopez, Massimo, Di Lauro, Luigi
Publicado 2011

Predicting of Sentinel Lymph Node Status in Breast Cancer Patients with Clinically Negative Nodes: A Validation Study

por Fanizzi, Annarita, Pomarico, Domenico, Paradiso, Angelo, Bove, Samantha, Diotaiuti, Sergio, Didonna, Vittorio, Giotta, Francesco, La Forgia, Daniele, Latorre, Agnese, Pastena, Maria Irene, Tamborra, Pasquale, Zito, Alfredo, Lorusso, Vito, Massafra, Raffaella
Publicado en Cancers (Basel) (2021)

Response Predictivity to Neoadjuvant Therapies in Breast Cancer: A Qualitative Analysis of Background Parenchymal Enhancement in DCE-MRI

por La Forgia, Daniele, Vestito, Angela, Lasciarrea, Maurilia, Comes, Maria Colomba, Diotaiuti, Sergio, Giotta, Francesco, Latorre, Agnese, Lorusso, Vito, Massafra, Raffaella, Palmiotti, Gennaro, Rinaldi, Lucia, Signorile, Rahel, Gatta, Gianluca, Fanizzi, Annarita
Publicado en J Pers Med (2021)

Early Prediction of Breast Cancer Recurrence for Patients Treated with Neoadjuvant Chemotherapy: A Transfer Learning Approach on DCE-MRIs

por Comes, Maria Colomba, La Forgia, Daniele, Didonna, Vittorio, Fanizzi, Annarita, Giotta, Francesco, Latorre, Agnese, Martinelli, Eugenio, Mencattini, Arianna, Paradiso, Angelo Virgilio, Tamborra, Pasquale, Terenzio, Antonella, Zito, Alfredo, Lorusso, Vito, Massafra, Raffaella
Publicado en Cancers (Basel) (2021)

Biological characterization and selection criteria of adjuvant chemotherapy for early breast cancer: experience from the Italian observational NEMESI study

por Clavarezza, Matteo, Mustacchi, Giorgio, Casadei Gardini, Andrea, Del Mastro, Lucia, De Matteis, Andrea, Riccardi, Ferdinando, Adamo, Vincenzo, Aitini, Enrico, Amoroso, Domenico, Marchetti, Paolo, Gori, Stefania, Carrozza, Francesco, Maiello, Evaristo, Giotta, Francesco, Dondi, Davide, Venturini, Marco
Publicado 2012

A Clinical Decision Support System for Predicting Invasive Breast Cancer Recurrence: Preliminary Results

por Massafra, Raffaella, Latorre, Agnese, Fanizzi, Annarita, Bellotti, Roberto, Didonna, Vittorio, Giotta, Francesco, La Forgia, Daniele, Nardone, Annalisa, Pastena, Maria, Ressa, Cosmo Maurizio, Rinaldi, Lucia, Russo, Anna Orsola Maria, Tamborra, Pasquale, Tangaro, Sabina, Zito, Alfredo, Lorusso, Vito
Publicado en Front Oncol (2021)

Metronomic oral chemotherapy with cyclophosphamide plus capecitabine combined with trastuzumab (HEX) as first line therapy of HER-2 positive advanced breast cancer: A phase II tria...

por Orlando, Laura, Lorusso, Vito, Giotta, Francesco, Di Maio, Massimo, Schiavone, Paola, Fedele, Palma, Quaranta, Annamaria, Caliolo, Chiara, Ciccarese, Mariangela, Cinefra, Margherita, Romito, Sante, Pisconti, Salvatore, Prete, Salvatore del, Aieta, Michele, Rizzi, Daniele, Maiello, Evaristo, Colucci, Giuseppe, Cinieri, Saverio
Publicado en Breast (2020)

Eribulin in Male Patients With Breast Cancer: The First Report of Clinical Outcomes

por Giotta, Francesco, Acito, Luigi, Candeloro, Giampiero, Del Medico, Pietro, Gadaleta-Caldarola, Gennaro, Giordano, Guido, Gueli, Rossana, Lugini, Antonio, Magri, Valentina, Mandarà, Marta, Masci, Giovanna, Pisconti, Salvatore, Pistelli, Mirco, Rizzi, Anna, Salesi, Nello, Schirone, Alessio, Scognamiglio, Giovanni, Tedeschi, Maria, Zucchinelli, Patrizia
Publicado en Oncologist (2016)

Outcomes of HER2-positive early breast cancer patients in the pre-trastuzumab and trastuzumab eras: a real-world multicenter observational analysis. The RETROHER study

por Vici, Patrizia, Pizzuti, Laura, Natoli, Clara, Moscetti, Luca, Mentuccia, Lucia, Vaccaro, Angela, Sergi, Domenico, Di Lauro, Luigi, Trenta, Patrizia, Seminara, Patrizia, Santini, Daniele, Iezzi, Laura, Tinari, Nicola, Bertolini, Ilaria, Sini, Valentina, Mottolese, Marcella, Giannarelli, Diana, Giotta, Francesco, Maugeri-Saccà, Marcello, Barba, Maddalena, Marchetti, Paolo, Michelotti, Andrea, Sperduti, Isabella, Gamucci, Teresa
Publicado 2014